FdaApplication

ANDA 219930

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSUN PHARMACEUTICAL INDUSTRIES INC
application_typeANDA
approval_date2026-01-27

Products (1)

ProductActive ingredientStrengthDosage form
DEFLAZACORTDEFLAZACORT22.75MG/MLSUSPENSION;ORAL

1 product